Serologically Documented Loracarbef (Lorabid)-Induced Immune Thrombocytopenia
Document Type
Article
Publication Date
5-1-2003
Description
We report here the first case of severe Immune thrombocytopenia induced by a secondgeneration cephalosporin antibiotic, Loracarbef. A 56-year old white female developed acute severe thrombocytopenia associated with acute respiratory symptoms following administration of Loracarbef. She responded to Loracarbef withdrawal and systemic corticosteroid administration. Loracarbef-dependent platelet-reactive antibodies were demonstrable in her serum by flow cytometry.
Citation Information
Aljitawi, O. S.; Krishnan, K.; Curtis, B. R.; Bougie, D. W.; and Aster, R. H.. 2003. Serologically Documented Loracarbef (Lorabid)-Induced Immune Thrombocytopenia. American Journal of Hematology. Vol.73(1). 41-43. https://doi.org/10.1002/ajh.10307 PMID: 12701119 ISSN: 0361-8609